期刊文献+

HCV 感染者体内病毒NS3 区部分区段的演变观测 被引量:3

Long term evolution of the region NS3 containing a CTL epitope of hepatitis C virus in three HCV infected men
原文传递
导出
摘要 目的 观察2 例慢性 H C V 携带者及1 例 H C V R N A 转阴者体内包含 C T L 抗原表位的 H C V N S3 区部分区段的长期演变。方法 通过反转录 P C R 扩增, M13 亚克隆,对3 例 H C V 感染者的 H C V N S3 区部分区段的一级结构进行测定。对感染者的 H L A 进行分型。根据基序( motif) 及 H L A 分型资料预测该区段中的 C T L 抗原表位。结果 文献报道的 H L A A2 限制的抗原表位在无 H L A A2 的感染者 C 中,1991 年至1996 年氨基酸序列无变异。具有 H L A A2 的感染者 W, Z 部分氨基酸序列中该表位的起始密码子发生无义突变,测序资料中包含稳定的变异位点的肽段,符合 M H C结合肽的基序( motif) 。结论 无义突变可能与 C T L 的免疫压力有关。稳定变异位点产生的原因可能是免疫逃避。 Longterm evolution of the region NS3 containing a CTL epitope of hepatitis C virus in three HCV infected men$$$$ GUO Huazhang, WANG Wenliang, WANG Tao, et al. Department of Pathology, Fourth Military Medical University, Xi'an 710032 【 Abstract 】 Objective To study the sequence evolution of HCV NS3 in two HCV carriers and one recovered person over 6 years. Methods Three patients were exposed to HCV prior to 1991. Blood samples taken in 1991, 1994 and 1996 were analyzed for nucleotide sequences. HLA types of these three persons were determined using antibodies. CTL epitopes were predicted using MHC binding motif. Results A reported HLA A2 restricted CTL epitope showed no alteration in the HLA A2 negative carrier over six years. In the HLA A2 positive individuals, some of the sequences showed amber mutation on the initial codon of the epitope. Peptides with persistent amino acid transitions contained MHC binding peptide motif. Conclusion The amber mutations and persistent amino acid transitions may be related to the immune escape. 【 Subject words 】 Hepatitis C virus Tlymphocytes Viral protein
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 1999年第5期372-375,共4页 Chinese Journal of Microbiology and Immunology
基金 国家自然科学基金
关键词 丙型肝炎病毒 T淋巴细胞 病毒蛋白质 Hepatitis C virus Tlymphocytes Viral protein
  • 相关文献

参考文献2

  • 1Rehermann B,J Virol,1996年,98卷,1431页
  • 2Guo H C,Nature,1992年,360卷,364页

同被引文献14

  • 1Kaplan DE, Reddy KR. Rising incidence of hepatocellular carcinoma: the role of hepatitis B and C; the impact on transplantation and outcomes [J]. Clin Liver Dis, 2003, 7(3): 683-714.
  • 2Hugle T, Cerny A. Current therapy and new molecular approaches to antiviral treatment and prevention of hepatitis C [J]. Rev Med Virol, 2003, 13(6): 361-371.
  • 3Wertheimer AM, Miner C, Lewinsohn DM, et al. Novel CD4+ and CD8+ T-cell determinants within the NS3 protein in subjects with spontaneously resolved HCV infection [J]. Hepatology, 2003, 37(3): 577-589.
  • 4Wodarz D. Hepatitis C virus dynamics and pathology: the role of CTL and antibody responses [J]. J Gen Virol, 2003, 84(Pt 7): 1743-1750.
  • 5Cerny A, McHutchison JG, Pasquinelli C, et al. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif [J]. J Clin Invest, 1995, 95(2): 521-530.
  • 6Rehermann B, Chang KM, McHutchinson J, et al. Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients [J]. J Virol, 1996, 70(10): 7092-7102.
  • 7Weiner A, Erickson AL, Kansopon J, et al. Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant [J]. Proc Natl Acad Sci USA, 1995, 92(7): 2755-2759.
  • 8Devereux HL, Brown D, Dusheiko GM, et al. Long-term evolution of the 5'UTR and a region of NS4 containing a CTL epitope of hepatitis C virus in two haemophilic patients [J]. J Gen Virol, 1997, 78 ( Pt 3): 583-590.
  • 9Willberg C, Barnes E, Klenerman P. HCV immunology-death and the maiden T cell [J]. Cell Death Differ, 2003, 10(Suppl 1): S39-S47.
  • 10[美]罗纳德·J·艾伦等.《证据法:文本、问题和案例》.张保生等译.高等教育出版社,2006年版,第852页.

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部